As reported, it was a case of an implant of a 29mm sapien 3 valve in aortic position by transfemoral approach.During procedure, there was no difficulty found during valve alignment in a straight section of the aorta.Nominal volume was used for the inflation of the balloon of the commander delivery system however, it burst circumferentially at the end of valve deployment.The valve was implanted in the correct position without embolization.The unit was removed as a single unit with no withdrawal issue.There was no harm to the patient due to this event.The patient outcome was good.
|
A supplemental mdr is being submitted for correction and additional information.The following sections of this report have been updated: corrected h.6 investigation conclusions and investigation findings.Added new information to h.6 type of investigation.The device was not returned to edwards lifesciences for evaluation.Without the device returned for evaluation, visual inspection, functional testing and dimensional analysis were unable to be completed.Imagery was provided from the site and revealed the following: balloon burst radially on inflation balloon area.A review of the risk management documentation was performed, and no evidence of product non-conformances or labeling/ifu inadequacies were identified in the evaluation.The complaint was confirmed based on evaluation of the provided imagery.However, as the device was not returned, engineering was unable to perform any visual examination, functional testing, or dimensional analysis.Therefore, the presence of a manufacturing non-conformance was unable to be determined.A review of the dhr, lot history and manufacturing mitigations did not provide any indication that a manufacturing non-conformance would have contributed to the complaint event.A review of ifu/training materials revealed no deficiencies.As reported, ''during procedure, no difficulty was found during valve alignment in a straight section of the aorta.Nominal volume was used for the inflation of the balloon of the commander delivery system but it burst circumferentially at the end of valve deployment''.Per follow-up with field clinical specialist, the degree of calcification in annulus/leaflets was considered as normal.The presence of calcification can create a challenging anatomy for balloon inflation.While the balloons are sufficiently designed and test to ensure the burst pressure is at or above the rated burst pressure, calcified nodules can compromise the structure of the balloon wall via following mechanisms such as puncture, local overstretching, open cell impingement, or stress concentration.As such, available information suggests that patient factors (calcification) may have contributed to the complaint event.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No ifu/labeling/training manual inadequacies were identified.Therefore, no corrective or preventative action nor product risk assessment is required at this time.
|